Fracture Risk Associated with Parkinsonism and Anti-Parkinson Drugs
- 20 August 2007
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 81 (3) , 153-161
Abstract
We studied fracture risk associated with parkinsonism (including Parkinson’s disease) and drugs used to treat these conditions in a case-control study. Cases were all subjects with any fracture during the year 2000 (n = 124,655). For each case, three controls (n = 373,962) matched on age and gender were randomly drawn from the background population. Exposure was a diagnosis of parkinsonism or use of anticholinergic drugs, levodopa alone or in combination with carbidopa, and/or catechol-O-methyl transferase (COMT) inhibitors, dopamine agonists, or monoamine oxidase B (MAO-B) inhibitors and a number of other confounders. Parkinsonism was associated with a crude odds ratio (OR) of any fracture of 2.2 (95% confidence interval [95% CI] 2.0–2.5) and an adjusted OR of 1.2 (95% CI 1.0–1.4), the risk being higher especially in males younger than 75 years. Levodopa was associated with an increased overall fracture risk and an increased risk of hip fractures in high doses. Dopamine agonists, anticholinergic drugs, and MAO-B inhibitors were not associated with increased fracture risk except for hip fractures at high doses for MAO-B inhibitors and hip fractures at median doses for dopamine agonists. Neuroleptics were associated with increased risk of fractures in almost all skeletal sites and doses. In conclusion, parkinsonism was associated with increased risk of fractures, especially among males younger than 75 years, and the risk was significantly attenuated upon adjustment for confounders. Use of neuroleptics and, to some degree, levodopa was associated with increased risk of fractures.Keywords
This publication has 25 references indexed in Scilit:
- Bone Mineral Density in Hip-Fracture Patients With Parkinson’s Disease: A Case-Control StudyArchives of Physical Medicine and Rehabilitation, 2006
- Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementiaMovement Disorders, 2006
- Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective studyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Assessment of risk factors for second hip fractures in Japanese elderlyOsteoporosis International, 2005
- Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort studyAge and Ageing, 2005
- Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromesMovement Disorders, 2004
- Long‐Term Prediction of Incident Hip Fracture Risk in Elderly White Women: Study of Osteoporotic FracturesJournal of the American Geriatrics Society, 2004
- Amelioration of osteopenia and hypovitaminosis D by 1alpha -hydroxyvitamin D3 in elderly patients with Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Reduced Bone Density of the Hip in Elderly Patients with Parkinson's DiseaseAge and Ageing, 1995
- Fracture Risk in Patients with Parkinsonism: A Population-based Study in Olmsted County, MinnesotaAge and Ageing, 1992